FMDGX | VMGIX | FMDGX / VMGIX | |
Total Expense Ratio | 0.05 | 0.19 | 26% |
Annual Report Gross Expense Ratio | 0.05 | 0.19 | 26% |
Fund Existence | 6 years | 19 years | - |
Gain YTD | 11.464 | 13.334 | 86% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 3.43B | 32.3B | 11% |
Annual Yield % from dividends | 0.41 | 0.51 | 80% |
Returns for 1 year | 28.65 | 25.14 | 114% |
Returns for 3 years | 70.38 | 55.52 | 127% |
Returns for 5 years | 63.06 | 62.58 | 101% |
Returns for 10 years | N/A | 184.28 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IBB | 143.12 | 2.77 | +1.97% |
iShares Biotechnology ETF | |||
VGM | 9.71 | 0.16 | +1.68% |
Invesco Trust Investment Grade Municipals | |||
IPB | 25.72 | 0.02 | +0.06% |
Merrill Lynch Depositor | |||
UJUN | 36.36 | -0.03 | -0.08% |
Innovator U.S. Equity Ultra BffrETF™-Jun | |||
CANQ | 29.41 | -0.04 | -0.15% |
Calamos Nasdaq® Equity & Income ETF |